摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

trifluoro-methanesulfonic acid 2-(5-methoxy-benzoimidazol-1-yl)-quinolin-8-yl ester | 343786-52-7

中文名称
——
中文别名
——
英文名称
trifluoro-methanesulfonic acid 2-(5-methoxy-benzoimidazol-1-yl)-quinolin-8-yl ester
英文别名
[2-(5-methoxybenzimidazol-1-yl)quinolin-8-yl] trifluoromethanesulfonate
trifluoro-methanesulfonic acid 2-(5-methoxy-benzoimidazol-1-yl)-quinolin-8-yl ester化学式
CAS
343786-52-7
化学式
C18H12F3N3O4S
mdl
——
分子量
423.372
InChiKey
BYLCHSBMGREZSB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.4
  • 重原子数:
    29
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    91.7
  • 氢给体数:
    0
  • 氢受体数:
    9

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] NOVEL BENZOIMIDAZOLE DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS<br/>[FR] NOUVEAUX DERIVES BENZOIMIDAZOLE CONVENANT COMME AGENTS ANTIPROLIFERATIFS
    申请人:PFIZER PROD INC
    公开号:WO2001040217A1
    公开(公告)日:2001-06-07
    The invention relates to compounds of formula (1) and to pharmaceutically acceptable salts, prodrugs and solvates thereof, wherein R?1, R7, R8, R9, R10, and R11¿ are as defined herein. The invention also relates to methods of treating abnormal cell growth, such as cancer, in mammals by administering the compounds of formula 1 and to pharmaceutical compositions for treating such disorders which contain the compounds of formula (1). The invention also relates to methods of preparing the compounds of formula (1).
    本发明涉及公式(1)的化合物及其药学上可接受的盐、前药和溶剂化物,其中R?1、R7、R8、R9、R10和R11¿的定义如本文所述。本发明还涉及通过给哺乳动物施用公式1的化合物来治疗异常细胞生长(如癌症)的方法,以及用含有公式(1)化合物的药物组合物来治疗此类疾病的药物组合物的方法。本发明还涉及制备公式(1)化合物的方法。
  • Novel benzoimidazole derivatives useful as antiproliferative agents
    申请人:Kath C. John
    公开号:US20050124599A1
    公开(公告)日:2005-06-09
    The invention relates to compounds of the formula 1 and to pharmaceutically acceptable salts, prodrugs and solvates thereof, wherein R 1 , R 2 , R 3 , and R 4 are as defined herein. The invention also relates to methods of treating abnormal cell growth, such as cancer, in mammals by administering the compounds of formula 1 and to pharmaceutical compositions for treating such disorders which contain the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1.
    本发明涉及公式1的化合物及其药学上可接受的盐、前药和溶剂化物,其中R1、R2、R3和R4如本文所定义。本发明还涉及通过给哺乳动物施用公式1的化合物来治疗异常细胞生长(如癌症)的方法,以及含有公式1化合物的用于治疗此类疾病的药物组合物。本发明还涉及制备公式1化合物的方法。
  • Benzoimidazole derivatives useful as antiproliferative agents
    申请人:Pfizer Inc
    公开号:US07071337B2
    公开(公告)日:2006-07-04
    The invention relates to compounds of the formula 1 and to pharmaceutically acceptable salts, prodrugs and solvates thereof, wherein R1, R2, R3, and R4 are as defined herein. The invention also relates to methods of treating abnormal cell growth, such as cancer, in mammals by administering the compounds of formula 1 and to pharmaceutical compositions for treating such disorders which contain the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1.
    本发明涉及到公式1的化合物及其药学上可接受的盐、前药和溶剂化物,其中R1、R2、R3和R4的定义如本文所述。本发明还涉及通过给予公式1的化合物治疗哺乳动物的异常细胞增长,如癌症的方法,以及包含公式1的化合物的用于治疗此类疾病的制药组合物。本发明还涉及制备公式1的化合物的方法。
  • NOVEL BENZOIMIDAZOLE DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS
    申请人:Pfizer Products Inc.
    公开号:EP1235825B1
    公开(公告)日:2006-01-25
  • US7019147B1
    申请人:——
    公开号:US7019147B1
    公开(公告)日:2006-03-28
查看更多